5.0
Feb 14, 2024
Current employee, less than 1 year
Recommend
CEO approval
Business Outlook
Pros
Company is focused on their people, patients and doing things the right way.
Cons
Still learning how to navigate the Rare Disease space and the differences from Oncology specialty.